Chembio Diagnostics' GAAP loss for 6 months of 2021 was $13.565 million, up 5.6% from $12.843 million in the previous year. Revenue increased 26.9% to $15.187 million from $11.971 million a year earlier.
Chembio Diagnostics' GAAP loss for 6 months of 2021 was $13.565 million, up 5.6% from $12.843 million in the previous year. Revenue increased 26.9% to $15.187 million from $11.971 million a year earlier. 
English (US) 